Microbiota Separation and C‐reactive Protein Elevation in Treatment‐naïve Pediatric Granulomatous Crohn Disease
Richárd Kellermayer(Baylor College of Medicine), Harland S. Winter(Massachusetts General Hospital), Jess L. Kaplan(Massachusetts General Hospital), Dorottya Nagy‐Szakal(Baylor College of Medicine), Stephen B. Cox(Texas Tech University), Jiří Bronský(Charles University), Scot E. Dowd(University of North Carolina at Chapel Hill), Sahna Reddy(Children's Nutrition Research Center at Baylor College of Medicine), Yan Sun(Lubbock Christian University), Sabina Mir(Baylor College of Medicine)
Cited by 51
Related Papers
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children
|Gastroenterology|2006|872
Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report
|PEDIATRICS|2010|870
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
|The Lancet|2017|647
Children with early-onset inflammatory bowel disease (IBD): Analysis of a pediatric IBD consortium registry
|The Journal of Pediatrics|2005|571